Return On Assets of Corbus Pharmaceuticals Holdings, Inc. from 30 Jun 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2015 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -58%, a 115% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Assets for 2025 was -58%, a 115% decline from 2024.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Assets for 2024 was -27%, a 76% increase from 2023.
  • Corbus Pharmaceuticals Holdings, Inc. annual Return On Assets for 2023 was -112%, a 109% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -58% -31% -115% 01 Oct 2025 31 Dec 2025
Q3 2025 -51% -18% -55% 01 Jul 2025 30 Sep 2025
Q2 2025 -40% +1.2% +3.1% 01 Apr 2025 30 Jun 2025
Q1 2025 -33% +25% +43% 01 Jan 2025 31 Mar 2025
Q4 2024 -27% +85% +76% 01 Oct 2024 31 Dec 2024
Q3 2024 -33% +63% +66% 01 Jul 2024 30 Sep 2024
Q2 2024 -41% +38% +48% 01 Apr 2024 30 Jun 2024
Q1 2024 -58% +16% +22% 01 Jan 2024 31 Mar 2024
Q4 2023 -112% -58% -109% 01 Oct 2023 31 Dec 2023
Q3 2023 -96% -49% -106% 01 Jul 2023 30 Sep 2023
Q2 2023 -78% -44% -126% 01 Apr 2023 30 Jun 2023
Q1 2023 -74% -39% -110% 01 Jan 2023 31 Mar 2023
Q4 2022 -53% -16% -42% 01 Oct 2022 31 Dec 2022
Q3 2022 -46% -10% -27% 01 Jul 2022 30 Sep 2022
Q2 2022 -35% +32% +48% 01 Apr 2022 30 Jun 2022
Q1 2022 -35% +54% +61% 01 Jan 2022 31 Mar 2022
Q4 2021 -37% +86% +70% 01 Oct 2021 31 Dec 2021
Q3 2021 -36% +131% +78% 01 Jul 2021 30 Sep 2021
Q2 2021 -67% +97% +59% 01 Apr 2021 30 Jun 2021
Q1 2021 -90% +23% +20% 01 Jan 2021 31 Mar 2021
Q4 2020 -123% -29% -30% 01 Oct 2020 31 Dec 2020
Q3 2020 -168% -85% -103% 01 Jul 2020 30 Sep 2020
Q2 2020 -164% -88% -115% 01 Apr 2020 30 Jun 2020
Q1 2020 -112% -12% -12% 01 Jan 2020 31 Mar 2020
Q4 2019 -94% -7.3% -8.3% 01 Oct 2019 31 Dec 2019
Q3 2019 -83% -12% -16% 01 Jul 2019 30 Sep 2019
Q2 2019 -76% -11% -16% 01 Apr 2019 30 Jun 2019
Q1 2019 -100% -36% -55% 01 Jan 2019 31 Mar 2019
Q4 2018 -87% -22% -35% 01 Oct 2018 31 Dec 2018
Q3 2018 -71% +6.2% +8% 01 Jul 2018 30 Sep 2018
Q2 2018 -66% +18% +21% 01 Apr 2018 30 Jun 2018
Q1 2018 -65% +24% +27% 01 Jan 2018 31 Mar 2018
Q4 2017 -65% +48% +43% 01 Oct 2017 31 Dec 2017
Q3 2017 -77% +13% +15% 01 Jul 2017 30 Sep 2017
Q2 2017 -83% -3.6% -4.5% 01 Apr 2017 30 Jun 2017
Q1 2017 -89% -0.4% -0.45% 01 Jan 2017 31 Mar 2017
Q4 2016 -113% -27% -31% 01 Oct 2016 31 Dec 2016
Q3 2016 -91% -3.2% -3.6% 01 Jul 2016 30 Sep 2016
Q2 2016 -80% +3.1% +3.8% 01 Apr 2016 30 Jun 2016
Q1 2016 -88% 01 Jan 2016 31 Mar 2016
Q4 2015 -86% 01 Oct 2015 31 Dec 2015
Q3 2015 -88% 01 Jul 2015 30 Sep 2015
Q2 2015 -83% 01 Apr 2015 30 Jun 2015

Corbus Pharmaceuticals Holdings, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -58% -31% -115% 01 Jan 2025 31 Dec 2025
2024 -27% +85% +76% 01 Jan 2024 31 Dec 2024
2023 -112% -58% -109% 01 Jan 2023 31 Dec 2023
2022 -53% -16% -42% 01 Jan 2022 31 Dec 2022
2021 -37% +86% +70% 01 Jan 2021 31 Dec 2021
2020 -123% -29% -30% 01 Jan 2020 31 Dec 2020
2019 -94% -7.3% -8.3% 01 Jan 2019 31 Dec 2019
2018 -87% -22% -35% 01 Jan 2018 31 Dec 2018
2017 -65% +48% +43% 01 Jan 2017 31 Dec 2017
2016 -113% -27% -31% 01 Jan 2016 31 Dec 2016
2015 -86% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.